Literature DB >> 24105473

Methods to elicit probability distributions from experts: a systematic review of reported practice in health technology assessment.

Bogdan Grigore1, Jaime Peters, Christopher Hyde, Ken Stein.   

Abstract

BACKGROUND: Elicitation is a technique that can be used to obtain probability distribution from experts about unknown quantities. We conducted a methodology review of reports where probability distributions had been elicited from experts to be used in model-based health technology assessments.
METHODS: Databases including MEDLINE, EMBASE and the CRD database were searched from inception to April 2013. Reference lists were checked and citation mapping was also used. Studies describing their approach to the elicitation of probability distributions were included. Data was abstracted on pre-defined aspects of the elicitation technique. Reports were critically appraised on their consideration of the validity, reliability and feasibility of the elicitation exercise.
RESULTS: Fourteen articles were included. Across these studies, the most marked features were heterogeneity in elicitation approach and failure to report key aspects of the elicitation method. The most frequently used approaches to elicitation were the histogram technique and the bisection method. Only three papers explicitly considered the validity, reliability and feasibility of the elicitation exercises.
CONCLUSION: Judged by the studies identified in the review, reports of expert elicitation are insufficient in detail and this impacts on the perceived usability of expert-elicited probability distributions. In this context, the wider credibility of elicitation will only be improved by better reporting and greater standardisation of approach. Until then, the advantage of eliciting probability distributions from experts may be lost.

Entities:  

Mesh:

Year:  2013        PMID: 24105473     DOI: 10.1007/s40273-013-0092-z

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  25 in total

1.  Expert judgement in pharmacoeconomic studies. Guidance and future use.

Authors:  C Evans; B Crawford
Journal:  Pharmacoeconomics       Date:  2000-06       Impact factor: 4.981

Review 2.  Review of guidelines for good practice in decision-analytic modelling in health technology assessment.

Authors:  Z Philips; L Ginnelly; M Sculpher; K Claxton; S Golder; R Riemsma; N Woolacoot; J Glanville
Journal:  Health Technol Assess       Date:  2004-09       Impact factor: 4.014

Review 3.  Introduction to health measurement scales.

Authors:  András P Keszei; Márta Novak; David L Streiner
Journal:  J Psychosom Res       Date:  2010-04       Impact factor: 3.006

4.  Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra.

Authors:  Karl Claxton; Mark Sculpher; Chris McCabe; Andrew Briggs; Ron Akehurst; Martin Buxton; John Brazier; Tony O'Hagan
Journal:  Health Econ       Date:  2005-04       Impact factor: 3.046

Review 5.  The cost-effectiveness of screening for oral cancer in primary care.

Authors:  P M Speight; S Palmer; D R Moles; M C Downer; D H Smith; M Henriksson; F Augustovski
Journal:  Health Technol Assess       Date:  2006-04       Impact factor: 4.014

6.  Modeling payback from research into the efficacy of left-ventricular assist devices as destination therapy.

Authors:  Alan J Girling; Guy Freeman; Jason P Gordon; Philip Poole-Wilson; David A Scott; Richard J Lilford
Journal:  Int J Technol Assess Health Care       Date:  2007       Impact factor: 2.188

Review 7.  Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses.

Authors:  T Colbourn; C Asseburg; L Bojke; Z Philips; K Claxton; A E Ades; R E Gilbert
Journal:  Health Technol Assess       Date:  2007-08       Impact factor: 4.014

8.  The cost-effectiveness of an RCT to establish whether 5 or 10 years of bisphosphonate treatment is the better duration for women with a prior fracture.

Authors:  Matt D Stevenson; Jeremy E Oakley; Myfawny Lloyd Jones; Alan Brennan; Juliet E Compston; Eugene V McCloskey; Peter L Selby
Journal:  Med Decis Making       Date:  2009-06-09       Impact factor: 2.583

9.  Belief elicitation to populate health economic models of medical diagnostic devices in development.

Authors:  Wieke Haakma; Lotte M G Steuten; Laura Bojke; Maarten J IJzerman
Journal:  Appl Health Econ Health Policy       Date:  2014-06       Impact factor: 2.561

Review 10.  Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling.

Authors:  C Meads; P Auguste; C Davenport; S Małysiak; S Sundar; M Kowalska; A Zapalska; P Guest; S Thangaratinam; P Martin-Hirsch; E Borowiack; P Barton; T Roberts; K Khan
Journal:  Health Technol Assess       Date:  2013-03       Impact factor: 4.014

View more
  13 in total

1.  Informing Reimbursement Decisions Using Cost-Effectiveness Modelling: A Guide to the Process of Generating Elicited Priors to Capture Model Uncertainties.

Authors:  Laura Bojke; Bogdan Grigore; Dina Jankovic; Jaime Peters; Marta Soares; Ken Stein
Journal:  Pharmacoeconomics       Date:  2017-09       Impact factor: 4.981

2.  The Use of Expert Elicitation among Computational Modeling Studies in Health Research: A Systematic Review.

Authors:  Christopher J Cadham; Marie Knoll; Luz María Sánchez-Romero; K Michael Cummings; Clifford E Douglas; Alex Liber; David Mendez; Rafael Meza; Ritesh Mistry; Aylin Sertkaya; Nargiz Travis; David T Levy
Journal:  Med Decis Making       Date:  2021-10-25       Impact factor: 2.749

3.  Reporting Guidelines for the Use of Expert Judgement in Model-Based Economic Evaluations.

Authors:  Cynthia P Iglesias; Alexander Thompson; Wolf H Rogowski; Katherine Payne
Journal:  Pharmacoeconomics       Date:  2016-11       Impact factor: 4.981

Review 4.  Developing a reference protocol for structured expert elicitation in health-care decision-making: a mixed-methods study.

Authors:  Laura Bojke; Marta Soares; Karl Claxton; Abigail Colson; Aimée Fox; Christopher Jackson; Dina Jankovic; Alec Morton; Linda Sharples; Andrea Taylor
Journal:  Health Technol Assess       Date:  2021-06       Impact factor: 4.014

5.  Electrocardiographic Screening for Prolonged QT Interval to Reduce Sudden Cardiac Death in Psychiatric Patients: A Cost-Effectiveness Analysis.

Authors:  Antoine Poncet; Baris Gencer; Marc Blondon; Marianne Gex-Fabry; Christophe Combescure; Dipen Shah; Peter J Schwartz; Marie Besson; François R Girardin
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

6.  EXPLICIT: a feasibility study of remote expert elicitation in health technology assessment.

Authors:  Bogdan Grigore; Jaime Peters; Christopher Hyde; Ken Stein
Journal:  BMC Med Inform Decis Mak       Date:  2017-09-04       Impact factor: 2.796

7.  A comparison of two methods for expert elicitation in health technology assessments.

Authors:  Bogdan Grigore; Jaime Peters; Christopher Hyde; Ken Stein
Journal:  BMC Med Res Methodol       Date:  2016-07-26       Impact factor: 4.615

Review 8.  Experiences of Structured Elicitation for Model-Based Cost-Effectiveness Analyses.

Authors:  Marta O Soares; Linda Sharples; Alec Morton; Karl Claxton; Laura Bojke
Journal:  Value Health       Date:  2018-04-25       Impact factor: 5.725

9.  Concepts of 'personalization' in personalized medicine: implications for economic evaluation.

Authors:  Wolf Rogowski; Katherine Payne; Petra Schnell-Inderst; Andrea Manca; Ursula Rochau; Beate Jahn; Oguzhan Alagoz; Reiner Leidl; Uwe Siebert
Journal:  Pharmacoeconomics       Date:  2015-01       Impact factor: 4.981

10.  Reference Case Methods for Expert Elicitation in Health Care Decision Making.

Authors:  Laura Bojke; Marta O Soares; Karl Claxton; Abigail Colson; Aimée Fox; Chris Jackson; Dina Jankovic; Alec Morton; Linda D Sharples; Andrea Taylor
Journal:  Med Decis Making       Date:  2021-07-16       Impact factor: 2.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.